Implementing Risk-Based Approaches During Longer Clinical Trials Maximizes Financial Impact RESEARCH TRIANGLE PARK, NC--(Marketwired - March 29, 2017) - Life science firms look to risk-based monitoring (RBM) to reduce costs associated with clinical studies, according to a study by business...

Risk-Based Monitoring: Pharma Doesn't Need to Reinvent the Wheel RESEARCH TRIANGLE PARK, NC--(Marketwired - November 03, 2014) - Encouraged by favorable FDA and EMA publications, a significantly increasing percentage of life sciences companies have begun...